Dream Big Health (DBH) is a market access, commercialization, and HEOR evidence generation firm
Recent Blogs
Previous Collaborators
Testimonials
We wanted to understand the reimbursement roadmap for our cardiology device, one that recently received FDA breakthrough designation. The DBH team did a great job outlining the viable coding and payment pathways available to us including respective requirements, processes, considerations and other very useful information. These are highly specialized and complex pathways with lots of nuances. Knowing what our options are and what the processes entail enables us to move forward with confidence. We're glad to have DBH by our side to help guide the way.
Ken Richards, CAO/CFO, Advanced Bifurcation Systems Inc
That [CPT Editorial Review] was a breeze like the PLA [Proprietary Laboratory Analysis, CPT Code] meeting.
We were rescued by Darron and Holly at the right time with the edits. I am glad that it worked out in a timely manner.
We will get our CPT code by Jan 1, 2023!!
Ram Vairavan, Senior Vice President, Commercial Operations, DiaCarta
Working with the Dream Big Health team was an exceptional experience. Their expertise in competitive analysis, pricing, and go-to-market strategies provided us with invaluable insights. The professionalism and dedication they demonstrated significantly enhanced our business operations, particularly in fundraising and strategic planning.
I-Lin Tsai, Co-founder, Astron Medtech
Dream Big Health's knowledge of coding and reimbursement in our area of expertise was very impressive. The deliverables provided critical information on office workflows, billing and reimbursement for services across 4 specialties. The CPT and ICD10 specific coding analysis and flowcharts, along with pricing information and billing considerations provided us with a clear understanding and roadmap. Thank you, DBH!
José Stuchi, CEO & Co-Founder
Phelcom Technologies
I am very pleased with Dream Big Health's depth of knowledge and professionalism, and we leveraged their expertise to submit a compelling Phase 2 SBIR grant proposal. Highly recommended!
Adam Watson, PhD
Co-Founder and CEO MeCo Diagnostics
